Polymeric contrast agent with targeting potential

Area of Science:

• Biomaterials Science
• Nanotechnology
• Medical Imaging

Background:

• Poly (lactid acid) (PLA) microcapsules are biodegradable and can be functionalized for targeted applications.
• Integrins, such as alphavbeta3 and alphavbeta5, are upregulated during angiogenesis and are implicated in cancer progression.
• Targeted delivery systems are crucial for enhancing the specificity of diagnostic and therapeutic agents.

Purpose of the Study:

• To conjugate the Arg-Gly-Asp (RGD) peptide sequence to biodegradable poly (lactid acid) (PLA) microcapsules.
• To evaluate the potential of RGD-conjugated microcapsules as targeted ultrasound contrast agents for cancer imaging.
• To investigate the specific binding of modified microcapsules to cancer cells expressing target integrins.

Main Methods:

• Synthesis of hollow, biodegradable PLGA microcapsules.
• Conjugation of the RGD peptide sequence to the surface of the microcapsules.
• In vitro evaluation of echogenicity and cell adhesion using the MDA-MB-231 breast cancer cell line.
• Control experiments included unmodified microcapsules and RGD-saturated cells.

Main Results:

• RGD-conjugated microcapsules demonstrated high echogenicity (up to 20 dB enhancement in vitro).
• Specific adherence of modified microcapsules to MDA-MB-231 breast cancer cells was observed in static experiments.
• No adherence was found with unmodified microcapsules or when cells were pre-saturated with the RGD ligand.

Conclusions:

• RGD-conjugated PLA microcapsules show promise as targeted ultrasound contrast agents.
• Specific targeting of cancer cells via integrin recognition is feasible.
• This approach could enable ultrasound imaging for distinguishing malignant from benign tissues.